WallStreetZenWallStreetZen

NASDAQ: DRMA
Dermata Therapeutics Inc Stock

$0.40-0.02 (-4.76%)
Updated Apr 11, 2024
DRMA Price
$0.40
Fair Value Price
N/A
Market Cap
$2.66M
52 Week Low
$0.37
52 Week High
$3.93
P/E
-0.15x
P/B
0.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$7.79M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.26
Operating Cash Flow
-$6M
Beta
0.95
Next Earnings
May 16, 2024
Ex-Dividend
N/A
Next Dividend
N/A

DRMA Overview

Dermata Therapeutics, Inc. is a clinical-stage biotechnology company developing and commercializing treatments for medical and aesthetic skin conditions. Its lead candidates are DMT310 and DMT410. Known as Dermata Therapeutics, LLC until 2021, the company was founded in 2014 and is headquartered in San Diego, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DRMA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DRMA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DRMA is good value based on its book value relative to its share price (0.42x), compared to the US Biotechnology industry average (6.04x)
P/B vs Industry Valuation
DRMA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more DRMA due diligence checks available for Premium users.

Be the first to know about important DRMA news, forecast changes, insider trades & much more!

DRMA News

Valuation

DRMA fair value

Fair Value of DRMA stock based on Discounted Cash Flow (DCF)
Price
$0.40
Fair Value
$9.36
Undervalued by
95.73%
DRMA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

DRMA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.15x
Industry
14.34x
Market
43.63x

DRMA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.42x
Industry
6.04x
DRMA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DRMA's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.1M
Profit Margin
0%

Assets to liabilities

Assets
$8.0M
Liabilities
$1.6M
Debt to equity
0.26
DRMA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.1M
Investing
$0.0
Financing
$2.0M

DRMA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
DRMA$2.66M-4.53%-0.15x0.42x
CYTO$2.69M-9.00%-0.21x0.37x
NBY$2.71M-1.10%-0.02x0.82x
CYCC$2.56M-5.37%-0.07x4.21x
CNSP$2.55M+3.45%-0.05x-0.58x

Dermata Therapeutics Stock FAQ

What is Dermata Therapeutics's quote symbol?

(NASDAQ: DRMA) Dermata Therapeutics trades on the NASDAQ under the ticker symbol DRMA. Dermata Therapeutics stock quotes can also be displayed as NASDAQ: DRMA.

If you're new to stock investing, here's how to buy Dermata Therapeutics stock.

What is the 52 week high and low for Dermata Therapeutics (NASDAQ: DRMA)?

(NASDAQ: DRMA) Dermata Therapeutics's 52-week high was $3.93, and its 52-week low was $0.37. It is currently -89.82% from its 52-week high and 8.11% from its 52-week low.

How much is Dermata Therapeutics stock worth today?

(NASDAQ: DRMA) Dermata Therapeutics currently has 6,660,840 outstanding shares. With Dermata Therapeutics stock trading at $0.40 per share, the total value of Dermata Therapeutics stock (market capitalization) is $2.66M.

Dermata Therapeutics stock was originally listed at a price of $83.04 in Aug 13, 2021. If you had invested in Dermata Therapeutics stock at $83.04, your return over the last 2 years would have been -99.52%, for an annualized return of -93.06% (not including any dividends or dividend reinvestments).

How much is Dermata Therapeutics's stock price per share?

(NASDAQ: DRMA) Dermata Therapeutics stock price per share is $0.40 today (as of Apr 11, 2024).

What is Dermata Therapeutics's Market Cap?

(NASDAQ: DRMA) Dermata Therapeutics's market cap is $2.66M, as of Apr 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Dermata Therapeutics's market cap is calculated by multiplying DRMA's current stock price of $0.40 by DRMA's total outstanding shares of 6,660,840.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.